Kaya, A. H. Et Al. 2017. Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting. BALKAN MEDICAL JOURNAL , vol.34, no.2 , 132-139.

Kaya, A. H., Tekgunduz, E., Duygu, F., Koca, D., Bekdemir, F., Batgi, H., ... Uncu, B. U.(2017). Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting. BALKAN MEDICAL JOURNAL , vol.34, no.2, 132-139.

Kaya, Ali Et Al. "Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting," BALKAN MEDICAL JOURNAL , vol.34, no.2, 132-139, 2017

Kaya, Ali H. Et Al. "Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting." BALKAN MEDICAL JOURNAL , vol.34, no.2, pp.132-139, 2017

Kaya, A. H. Et Al. (2017) . "Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting." BALKAN MEDICAL JOURNAL , vol.34, no.2, pp.132-139.

@article{article, author={Ali Hakan Kaya Et Al. }, title={Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting}, journal={BALKAN MEDICAL JOURNAL}, year=2017, pages={132-139} }